CD169+ macrophages are involved in bacterial infections with sialylated lipopolysaccharides, lipooligosaccharides, or capsular polysaccharides, including Group B Streptococcus (GBS), Streptococcus pneumoniae, and Campylobacter jejuni [11]. Here, SIGLEC1 is linked to bacterial infectious disease.